Adcy2 Protein — Adenylate Cyclase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Adenylate Cyclase 2 |
|---|
| Protein Name | ADCY2 (Membrane-bound adenylyl cyclase 2) |
| Gene | ADCY2 |
| UniProt ID | Q08462 |
| Protein Family | Adenylate cyclase family (Class III) |
| Molecular Weight | ~120 kDa |
| Expression | Brain (widespread), lung, liver, heart |
ADCY2 (Adenylate Cyclase 2) is a membrane-bound enzyme that catalyzes the conversion of ATP to cyclic AMP (cAMP), a pivotal second messenger in cellular signaling. ADCY2 is one of nine mammalian adenylate cyclase isoforms, distinguished by its regulatory properties and expression patterns. It is widely expressed in the brain and various peripheral tissues.
ADCY2 has a characteristic architecture:
- Two transmembrane modules: Each with six transmembrane helices
- Cytoplasmic catalytic domains: C1a and C2a form the dimeric catalytic core
- Forskolin binding site: On the C2 domain
- Gαs binding pocket: Regulates enzyme activation
- Regulatory phosphorylation sites: PKA and CaMKII can phosphorylate ADCY2
The catalytic domains are highly conserved across isoforms, while regulatory domains confer isoform-specific control.
ADCY2 generates cAMP in response to:
- Gαs-coupled receptors: Including dopamine D1, β-adrenergic, and serotonin receptors
- Forskolin: Direct pharmacological activation
- Gβγ complexes: Can stimulate ADCY2 activity
- Calcium/calmodulin: Some isoforms respond to Ca²⁺
cAMP produced by ADCY2 regulates:
- Long-term potentiation (LTP): PKA-dependent synaptic strengthening
- Long-term depression (LTD): cAMP/PKA mechanisms
- Memory consolidation: CREB-mediated gene transcription
- Synaptic vesicle cycling: cAMP effects on release machinery
ADCY2 contributes to localized cAMP signaling:
- Dendritic microdomains: Compartmentalized cAMP production
- Synaptic specialization: Localized signaling complexes
- Second messenger crosstalk: Interactions with Ca²⁺ and MAPK pathways
ADCY2 dysfunction in AD:
- cAMP dysregulation: Reduced adenylate cyclase activity
- Synaptic failure: Impaired cAMP-dependent plasticity
- Tau pathology: cAMP signaling interactions with tau
- Memory deficits: CREB-mediated transcription impairment
ADCY2 in dopaminergic systems:
- D1 receptor signaling: Mediates D1-dependent cAMP production
- Striatal function: Motor control through cAMP signaling
- L-DOPA response: Adenylate cyclase in treatment response
- Neuroprotection: cAMP-activated survival pathways
ADCY2 modulators for neurodegeneration:
- Forskolin derivatives: Direct adenylate cyclase activators
- PDE inhibitors: Enhance cAMP by preventing degradation
- GPCR agonists: Stimulate Gαs-coupled receptor signaling
- cAMP analogs: Bypass defective adenylate cyclase
ADCY2 expression patterns:
- Brain: High in cortex, hippocampus, basal ganglia
- Lung: Airway epithelial cells
- Heart: Cardiac myocytes
- Liver: Hepatocytes
ADCY2 associations with:
- Neuropsychiatric disorders: Schizophrenia, depression
- Cognitive function: Memory and learning
- Movement disorders: Parkinson's disease
- Metabolic conditions: cAMP in glucose homeostasis
ADCY2 intersects with neurodegeneration-related pathways:
- Amyloid precursor protein (APP): cAPP affects adenylate cyclase
- Alpha-synuclein: cAMP/synuclein interactions
- Tau: Kinase/phosphatase cAMP effects on tau
- Parkin: Ubiquitin-proteasome system links
The study of Adcy2 Protein — Adenylate Cyclase 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Hanoune & Defer, Regulation and role of adenylyl cyclase isoforms (2001)
- Dessauer, Adenylyl cyclase isoforms (2007)
- Ferguson, G protein-coupled receptor signaling in the CNS (2001)